Quick Takeaways
- JPMORGAN CHASE & CO filed SCHEDULE 13G/A for TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA).
- Disclosed ownership: 2.8%.
- Date of event: 28 Feb 2025.
JPMORGAN CHASE & CO - 28 Feb 2025 SCHEDULE 13G/A Report for TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- TNYA
- Shares outstanding
- 81,568,357 shares
- Disclosed Ownership
- 2,283,914 shares
- Ownership
- 2.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Mar 2025, 10:52:50 UTC
- Date of event
- 28 Feb 2025
- Previous filing
- 10 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JPMORGAN CHASE & CO disclosed 2.8% ownership in TENAYA THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TNYA) on 28 Feb 2025."
What Changed
- Previous schedule filing date: 10 Feb 2025.
- Current filing was accepted on 06 Mar 2025, 10:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 2.8% | 2,283,914 | 1,901,559 | 0 | Rachel Tsvaygoft | Vice President |